Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Recent Advances in Pathophysiology and Therapeutic Approaches in Epilepsy"
A special issue of Brain Sciences (ISSN 2076-3425).
Deadline for manuscript submissions: 30 September 2023 | Viewed by 4632
Special Issue Editors
Interests: neurobiology of epilepsy; neurotherapeutics; neurotoxicology and neurodegeneration
Interests: neurobiology of epilepsy; ageing; electrophysiology of Brain; behavioral neuroscience, neurotoxicity
Interests: neurogenesis; aging; neurodegeneration; neuroinflammation; cognition
Special Issue Information
Epilepsy is a common neurological disorder affecting about 70 million population around the world. The major characteristics of this neurological disorder are the onset of sudden and recurrent seizures. The existing treatment options for epilepsy are limited to only relieving symptoms, but do not alter the progression of epilepsy. Furthermore, more than 30% of patients using existing antiseizure drugs are refractory to epilepsy and long-term use of these drugs can cause a plethora of adverse effects.
Investigating biomarkers and underlying mechanisms of epileptogenesis may address the detailed pathophysiology for the progression and development of epilepsy in patients. The identification of drugs and therapies to prevent epilepsy is critical, yet is unmet in current pharmacological approaches. Therefore, basic studies aiming at testing the potential antiepileptic properties of new molecules are greatly needed.
The main goal of this Special Issue is to present novel approaches from the clinical and basic research prospective about development and progression of epilepsy as well as to address disease-modifying strategies. Additionally, we aim to explore new pharmacological targets and strategies, so we can help for the development of new therapeutic strategies to prevent epilepsy and halt its progression.
Authors are invited to submit relevant original research articles and review papers. Research involving basic and clinical studies to understand the underlying mechanisms of epileptogenesis and its therapeutics is welcomed.
Dr. Chandra Prakash
Prof. Dr. Deepak Sharma
Dr. Pavan Kumar
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- pathophysiology of epilepsy: human and animal
- underlying mechanism of epileptogenesis
- animal models of epilepsy
- antiepileptic drugs: classic and novel
- antiseizure medications: novel therapeutic options
- adverse effects of antiseizures drugs